Outcome and Toxicity of an Ifosfamide-Based Soft Tissue Sarcoma Treatment Protocol in Children. The Importance of Local Therapy
Background. Although the survival of children with soft tissue sarcoma (STS) has improved considerably, the outcome of patients with metastatic disease, and those with primary tumours of the extremities or parameningeal sites remains disappointing. We describe the clinical outcome of an ifosfamide-b...
Main Authors: | S. Murray Yule, Roderick Skinner, Martin W. English, Mike Cole, Andrew D. J. Pearson, Helen H. Lucraft, Alan W. Craft |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1998-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1080/13577149877939 |
Similar Items
-
Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report
by: Jones Robin L, et al.
Published: (2011-05-01) -
Ifosfamide-induced Encephalopathy in Patients With Uterine Sarcoma
by: Shih-Hung Tsai
Published: (2010-03-01) -
Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma
by: Juan Martin-Liberal, et al.
Published: (2013-01-01) -
Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
by: Michiel C. Verboom, et al.
Published: (2019-01-01) -
Current and future systemic treatment options for advanced soft-tissue sarcoma beyond anthracyclines and ifosfamide
by: Nadia Hindi, et al.
Published: (2017-01-01)